2 false false false false false false false false false false true false false false false false false No description of principal activity 2022-09-01 Sage Accounts Production Advanced 2023 - FRS102_2023 338,554 63,946 35 63,981 274,573 274,608 xbrli:pure xbrli:shares iso4217:GBP 06630131 2022-09-01 2023-08-31 06630131 2023-08-31 06630131 2022-08-31 06630131 2021-09-01 2022-08-31 06630131 2022-08-31 06630131 2021-08-31 06630131 bus:Director2 2022-09-01 2023-08-31 06630131 core:FurnitureFittings 2022-08-31 06630131 core:FurnitureFittings 2023-08-31 06630131 core:MotorVehicles 2023-08-31 06630131 core:FurnitureFittings 2022-09-01 2023-08-31 06630131 core:MotorVehicles 2022-09-01 2023-08-31 06630131 core:WithinOneYear 2023-08-31 06630131 core:WithinOneYear 2022-08-31 06630131 core:ShareCapital 2023-08-31 06630131 core:ShareCapital 2022-08-31 06630131 core:RetainedEarningsAccumulatedLosses 2023-08-31 06630131 core:RetainedEarningsAccumulatedLosses 2022-08-31 06630131 core:CostValuation core:Non-currentFinancialInstruments 2023-08-31 06630131 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2022-08-31 06630131 core:ImpairmentLossProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2023-08-31 06630131 core:Non-currentFinancialInstruments core:ProvisionsForImpairmentInvestments 2023-08-31 06630131 core:Non-currentFinancialInstruments 2023-08-31 06630131 core:Non-currentFinancialInstruments 2022-08-31 06630131 core:FurnitureFittings 2022-08-31 06630131 bus:SmallEntities 2022-09-01 2023-08-31 06630131 bus:AuditExemptWithAccountantsReport 2022-09-01 2023-08-31 06630131 bus:SmallCompaniesRegimeForAccounts 2022-09-01 2023-08-31 06630131 bus:PrivateLimitedCompanyLtd 2022-09-01 2023-08-31 06630131 bus:FullAccounts 2022-09-01 2023-08-31 06630131 core:ComputerEquipment 2022-08-31 06630131 core:ComputerEquipment 2022-09-01 2023-08-31 06630131 core:ComputerEquipment 2023-08-31 06630131 core:KeyManagementIndividualGroup1 2022-09-01 2023-08-31 06630131 core:KeyManagementIndividualGroup2 2022-09-01 2023-08-31 06630131 core:KeyManagementIndividualGroup1 core:DividendsPaidTransactions 2022-09-01 2023-08-31 06630131 core:KeyManagementIndividualGroup1 2021-09-01 2022-08-31 06630131 core:KeyManagementIndividualGroup1 2023-08-31 06630131 core:KeyManagementIndividualGroup1 2022-08-31
COMPANY REGISTRATION NUMBER: 06630131
Westbourne Medical Limited
Filleted Unaudited Financial Statements
31 August 2023
Westbourne Medical Limited
Statement of Financial Position
31 August 2023
2023
2022
Note
£
£
Fixed assets
Tangible assets
6
51,299
1,425
Investments
7
274,573
274,608
---------
---------
325,872
276,033
Current assets
Stocks
28,297
39,109
Debtors
8
56,088
62,006
Cash at bank and in hand
331,886
61,607
---------
---------
416,271
162,722
Creditors: amounts falling due within one year
9
327,020
136,837
---------
---------
Net current assets
89,251
25,885
---------
---------
Total assets less current liabilities
415,123
301,918
Provisions
12,825
271
---------
---------
Net assets
402,298
301,647
---------
---------
Capital and reserves
Called up share capital
2
2
Profit and loss account
402,296
301,645
---------
---------
Members` funds
402,298
301,647
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ended 31 August 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: - The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476; - The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
Westbourne Medical Limited
Statement of Financial Position (continued)
31 August 2023
These financial statements were approved by the board of directors and authorised for issue on 30 August 2024 , and are signed on behalf of the board by:
J P Birtwistle
Director
Company registration number: 06630131
Westbourne Medical Limited
Notes to the Financial Statements
Year ended 31 August 2023
1. Statutory information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 9 Westbourne Drive, Wilmslow, Cheshire, SK9 2GY.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102 Section 1A, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the Companies Act 2006.
3. Accounting policies
(a) Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
(b) Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied, stated net of Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
(c) Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
(d) Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
(e) Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fixtures, fittings and equipment
-
15% straight line
Motor vehicle
-
25% straight line
Computer equipment
-
33.33% straight line
(f) Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
(g) Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
(h) Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
(i) Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset.
(j) Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2022: 2 ).
5. Directors' remuneration
The directors' aggregate remuneration in respect of qualifying services was:
2023
2022
£
£
Remuneration
16,848
18,252
--------
--------
6. Tangible assets
Fixtures, fittings and equipment
Motor vehicles
Computer equipment
Total
£
£
£
£
Cost
At 1 September 2022
355
7,451
7,806
Additions
50,900
3,913
54,813
Disposals
( 869)
( 869)
----
--------
--------
--------
At 31 August 2023
355
50,900
10,495
61,750
----
--------
--------
--------
Depreciation
At 1 September 2022
189
6,192
6,381
Charge for the year
46
3,181
1,657
4,884
Disposals
( 814)
( 814)
----
--------
--------
--------
At 31 August 2023
235
3,181
7,035
10,451
----
--------
--------
--------
Carrying amount
At 31 August 2023
120
47,719
3,460
51,299
----
--------
--------
--------
At 31 August 2022
166
1,259
1,425
----
--------
--------
--------
7. Investments
Other investments other than loans
£
Cost
At 1 September 2022 and 31 August 2023
338,554
---------
Impairment
At 1 September 2022
63,946
Impairment losses
35
---------
At 31 August 2023
63,981
---------
Carrying amount
At 31 August 2023
274,573
---------
At 31 August 2022
274,608
---------
8. Debtors
2023
2022
£
£
Trade debtors
54,274
46,671
Other debtors
1,814
15,335
--------
--------
56,088
62,006
--------
--------
9. Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
11,729
27,566
Corporation tax
28,967
1,665
Social security and other taxes
41,804
4,883
Other creditors
244,520
102,723
---------
---------
327,020
136,837
---------
---------
10. Related party transactions
Mrs D Birtwistle and J P Birtwistle are related parties by virtue of their directorships of and shareholdings in the company. During the year, the company paid dividends to Mrs D Birtwistle and J P Birtwistle in the sum of £ 40,000 (2022: £ 33,680 ). During the year, Mrs D Birtwistle and J P Birtwistle operated a directors' loan account with the company such that, at the year end, they were owed the combined sum of £ 39,930 (2022: £ 97,174 ). These loans were interest free and repayable on demand.